# TelePharmaceutical Care Diabetes Trial

> **NCT05380596** · NA · UNKNOWN · sponsor: **Rio Grande do Sul State Health Department - SES/RS** · enrollment: 124 (estimated)

## Conditions studied

- Diabete Mellitus
- Diabete Type 2
- Telemedicine
- Telehealth

## Interventions

- **BEHAVIORAL:** Telepharmaceutical Care

## Key facts

- **NCT ID:** NCT05380596
- **Lead sponsor:** Rio Grande do Sul State Health Department - SES/RS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-01
- **Final completion:** 2023-01
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380596, "TelePharmaceutical Care Diabetes Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05380596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*